Literature DB >> 20735930

Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa.

Nicholas A Feasey1, Brett N Archer, Robert S Heyderman, Arvinda Sooka, Brigitte Dennis, Melita A Gordon, Karen H Keddy.   

Abstract

To determine the prevalence of invasive nontyphoid salmonellosis and typhoid fever in Malawi and South Africa, we compared case frequency and patient age distribution. Invasive nontyphoid salmonellosis showed a clear bimodal age distribution; the infection developed in women at a younger age than in men. Case frequency for typhoid fever was lower than for salmonellosis.

Entities:  

Mesh:

Year:  2010        PMID: 20735930      PMCID: PMC3294972          DOI: 10.3201/eid1609.100125

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Invasive nontyphoid salmonellosis (iNTS) was first described as an AIDS-related illness in Africa and the United States in the 1980s. Although incidence in industrialized countries declined, nontyphoid Salmonella (NTS) spp. serovars (predominantly S. enterica serovars Typhimurium and Enteritidis) remain a common cause of bloodstream and focal infection in sub-Saharan Africa for adults with HIV infection and children with HIV, malaria, and malnutrition. iNTS has a strong seasonal pattern in adults and children. In addition, epidemics of iNTS have been described as associated with the emergence of multidrug resistance in Malawi (). Similarly, multidrug resistance is well recognized in iNTS in South Africa (www.nicd.ac.za/pubs/survbull/2010/CommDisBullMay10_Vol0802.pdf). Death rates are 20%–25% among adults and children (). In sub-Saharan Africa, transmission is thought most likely to be between humans, and no food or animal source has been found, although epidemiologic data remain sparse (). In comparison to iNTS, S. enterica serovar Typhi is a highly adapted, invasive, human-restricted pathogen that in the 19th century caused considerable illness and death in the United States and Europe but now has the greatest impact in developing countries. In sub-Saharan Africa, perhaps surprisingly, typhoid fever is not associated with HIV among adults (). Regional data on the demography and prevalence of both iNTS and S. Typhi for sub-Saharan Africa are incomplete (). Estimates of incidence of iNTS among children, 175–388/100,000 (–), and among adult HIV-prevalent cohorts, 2,000–8,500/100,000 (–), have been made separately, in different locations, giving no overall demographic picture. Estimates of the incidence of typhoid fever have relied on limited available data from sub-Saharan Africa (). Although typhoid is usually regarded as an illness of school-age (>5 years of age) children and young adults, there is considerable heterogeneity; some sites in Asia report high incidences of typhoid fever among children <5 years of age (). We compared case frequency and patient age distribution for the predominant types of invasive salmonellosis among febrile patients of all ages treated at our 2 centers in 2 regions in sub-Saharan Africa, Malawi and South Africa, before 2004.

The Study

In Malawi, Queen Elizabeth Central Hospital is the government-funded hospital for Blantyre District, serving ≈1 million persons. From January 1998 through December 2004, persons from the community who came to the hospital with fever (adults >14 years, axillary temperature >37°C; and children <14 years and >1 month, temperature >37.5°C, and negative malaria test result) had venous blood taken for routine culture, as previously described (). During 1998–2000, a manual culture system was used. From December 2000 onward, the same volume of blood was cultured by using the BacT/Alert 3D automated system (bioMérieux, Marcy l’Etoile, France). All isolates were identified by using standard diagnostic techniques. Outbreaks caused by individual NTS serovars were observed during this period, occurred simultaneously among adults and children, and showed an identical age distribution to baseline data (). In South Africa, active laboratory-based surveillance for Salmonella spp. was introduced nationally in 2003. Data from January 2003 through December 2004 were collected by the Enteric Disease Reference Unit, the national reference center representing data from >250 diagnostic laboratories across South Africa, serving ≈46 million persons (www.nhls.ac.za). Samples from normally sterile sites (bloodstream, cerebrospinal fluid, pleural fluid) from patients admitted to hospitals in South Africa were collected according to the clinician’s judgment, and isolates were submitted to the local diagnostic laboratory, where they were identified by using standard diagnostic techniques before being sent to Enteric Disease Reference Unit for confirmation of identification and serotype. No major outbreaks of typhoid fever or iNTS were observed during this period.

Conclusions

In South Africa during 2003 and 2004, 1,318 cases of iNTS were microbiologically confirmed (67% S. Typhimurium, 10% S. Enteritidis, 7% S. Isangi, and 6% S. Dublin), and 105 cases of S. Typhi were identified under surveillance that included demographic data. In Malawi during 1998–2004, 62,778 blood samples were taken, of which 10,628 yielded pathogens. Information included 4,956 cases of iNTS (75% S. Typhimurium, 21% S. Enteritidis), for which demographic data were available for 4,044, and 105 cases of S. Typhi bacteremia, for which demographic data were available for 75. Age distribution of patients with of iNTS and typhoid fever in Malawi and South Africa are shown in Figure 1. Despite the potential differences in sampling and surveillance intensity between sites, the data show a similar pattern of age distribution for iNTS at both sites, with a clear bimodal distribution. A peak was seen during the first 2 years of life, which rapidly declined thereafter until a second peak at ≈30 years. This age distribution was the same for all individual NTS serovars apart from S. Isangi and reflects the well-described risk factors for NTS infection: malaria, malnutrition, and HIV among children, and HIV among adults. A relative paucity of iNTS in the first few months of life has been reported from the Malawi center (). We note that 32% (425/1,318) compared with 54% (2176/4044) of iNTS cases were in children <15 years of age for South Africa and Malawi, respectively. It is, however, not possible to say whether this observed difference may be explained by sampling bias, differences in population demographics, or iNTS specific risk factors in the 2 countries. Notably, patients from whom S. Isangi was isolated in South Africa were significantly younger (median age 5 years; p<0.001) than patients infected with other serovars.
Figure 1

A) Age and gender distribution of patients with invasive nontyphoid Salmonella spp. infections in A) South Africa, 2003–2004, and B) Blantyre, Malawi, 1998–2004; and age and gender distribution of patients with Salmonella enterica serovar Typhi infection in C) South Africa, 2003–2004, and D) Blantyre, Malawi, 1998–2004.

A) Age and gender distribution of patients with invasive nontyphoid Salmonella spp. infections in A) South Africa, 2003–2004, and B) Blantyre, Malawi, 1998–2004; and age and gender distribution of patients with Salmonella enterica serovar Typhi infection in C) South Africa, 2003–2004, and D) Blantyre, Malawi, 1998–2004. There was a significant gender difference in the age at which adults acquire iNTS (Figure 2). iNTS occurred in women at a younger age than men in South Africa (median age 30 years for women vs. 35 years for men; p<0.001) and Malawi (median age 33 years for women vs. 37 years for men; p<0.001). The principal risk factor for iNTS among adults is HIV (), and this finding is consistent with the observation that women acquire HIV infection at a younger age than men. The HIV prevalence in those 15–24 years of age is 3× greater among women than men across sub-Saharan Africa. In South Africa the difference is even more marked, and HIV prevalence peaks in women 25–29 years of age and in men 30–34 years of age ().
Figure 2

Age and gender distribution of adult patients (>14 years of age) with invasive nontyphoid Salmonella spp. infection in A) South Africa, 2003–2004, and B) Blantyre, Malawi, 1998–2004.

Age and gender distribution of adult patients (>14 years of age) with invasive nontyphoid Salmonella spp. infection in A) South Africa, 2003–2004, and B) Blantyre, Malawi, 1998–2004. The relative frequency of iNTS cases detected by both centers was much higher than that of S. Typhi, which suggests a substantially higher number of cases. However, the different sampling protocols do not permit comment on absolute incidence rates. Typhoid fever patients showed a markedly contrasting age distribution from that seen in iNTS, affecting mainly school-age children and younger adults, but differed slightly between the 2 sites. In Malawi, 15 of 75 typhoid cases were in preschool-age children, compared with only 5 of 105 of cases in South Africa. Again, the reasons for this cannot be determined. It is noteworthy that the relative case frequencies and age distributions of iNTS and typhoid are so contrasting. Unlike in industrialized countries, NTS in sub-Saharan Africa is thought to be transmitted person to person, and a unique pathovar, Salmonella Typhimurium ST313, has emerged that shows genomic degradation similar to that seen in the human-restricted S. Typhi (). Despite this evidence of convergent evolution, these data strongly suggest that the epidemiology and transmission routes of S. Typhi and NTS may be distinct. It remains to be seen what effects the wide availability of antiretroviral drugs or enhanced malaria eradication programs in sub-Saharan Africa will have on the demography of iNTS.
  14 in total

1.  23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort.

Authors:  Christine Watera; Jessica Nakiyingi; George Miiro; Richard Muwonge; James A G Whitworth; Charles F Gilks; Neil French
Journal:  AIDS       Date:  2004-05-21       Impact factor: 4.177

2.  Bacteremia among children admitted to a rural hospital in Kenya.

Authors:  James A Berkley; Brett S Lowe; Isaiah Mwangi; Thomas Williams; Evasius Bauni; Saleem Mwarumba; Caroline Ngetsa; Mary P E Slack; Sally Njenga; C Anthony Hart; Kathryn Maitland; Mike English; Kevin Marsh; J Anthony G Scott
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

3.  Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: zoonotic or anthroponotic transmission?

Authors:  Samuel Kariuki; Gunturu Revathi; Nyambura Kariuki; John Kiiru; Joyce Mwituria; Jane Muyodi; Jane W Githinji; Dorothy Kagendo; Agnes Munyalo; C Anthony Hart
Journal:  J Med Microbiol       Date:  2006-05       Impact factor: 2.472

Review 4.  Global trends in typhoid and paratyphoid Fever.

Authors:  John A Crump; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

5.  Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype.

Authors:  Robert A Kingsley; Chisomo L Msefula; Nicholas R Thomson; Samuel Kariuki; Kathryn E Holt; Melita A Gordon; David Harris; Louise Clarke; Sally Whitehead; Vartul Sangal; Kevin Marsh; Mark Achtman; Malcolm E Molyneux; Martin Cormican; Julian Parkhill; Calman A MacLennan; Robert S Heyderman; Gordon Dougan
Journal:  Genome Res       Date:  2009-11-09       Impact factor: 9.043

6.  The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children.

Authors:  Calman A MacLennan; Esther N Gondwe; Chisomo L Msefula; Robert A Kingsley; Nicholas R Thomson; Sarah A White; Margaret Goodall; Derek J Pickard; Stephen M Graham; Gordon Dougan; C Anthony Hart; Malcolm E Molyneux; Mark T Drayson
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 7.  Salmonella infections in immunocompromised adults.

Authors:  Melita A Gordon
Journal:  J Infect       Date:  2008-05-12       Impact factor: 6.072

8.  Community-acquired bacteremia among children admitted to a rural hospital in Mozambique.

Authors:  Betuel Sigaúque; Anna Roca; Inácio Mandomando; Luís Morais; Llorenç Quintó; Jahit Sacarlal; Eusébio Macete; Tacilta Nhamposa; Sónia Machevo; Pedro Aide; Quique Bassat; Azucena Bardají; Delino Nhalungo; Montse Soriano-Gabarró; Brendan Flannery; Clara Menendez; Myron M Levine; Pedro L Alonso
Journal:  Pediatr Infect Dis J       Date:  2009-02       Impact factor: 2.129

9.  A study of typhoid fever in five Asian countries: disease burden and implications for controls.

Authors:  R Leon Ochiai; Camilo J Acosta; M Carolina Danovaro-Holliday; Dong Baiqing; Sujit K Bhattacharya; Magdarina D Agtini; Zulfiqar A Bhutta; Do Gia Canh; Mohammad Ali; Seonghye Shin; John Wain; Anne-Laure Page; M John Albert; Jeremy Farrar; Remon Abu-Elyazeed; Tikki Pang; Claudia M Galindo; Lorenz von Seidlein; John D Clemens
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

10.  Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia.

Authors:  Godwin Enwere; Ekow Biney; Yin Bun Cheung; Syed M A Zaman; Brown Okoko; Claire Oluwalana; Adeola Vaughan; Brian Greenwood; Richard Adegbola; Felicity T Cutts
Journal:  Pediatr Infect Dis J       Date:  2006-08       Impact factor: 2.129

View more
  46 in total

Review 1.  Disseminated infections with antibiotic-resistant non-typhoidal Salmonella strains: contributions of host and pathogen factors.

Authors:  Kristen L Lokken; Gregory T Walker; Renée M Tsolis
Journal:  Pathog Dis       Date:  2016-10-08       Impact factor: 3.166

Review 2.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 3.  Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis.

Authors:  Melita A Gordon
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

Review 4.  Antimicrobial resistance and management of invasive Salmonella disease.

Authors:  Samuel Kariuki; Melita A Gordon; Nicholas Feasey; Christopher M Parry
Journal:  Vaccine       Date:  2015-04-23       Impact factor: 3.641

Review 5.  Typhoidal and non-typhoidal Salmonella infections in Africa.

Authors:  S I Smith; A Seriki; A Ajayi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-25       Impact factor: 3.267

6.  Non-typhoidal Salmonella gastroenteritis at a diarrheal hospital in Dhaka, Bangladesh, 1996-2011.

Authors:  Daniel T Leung; Sumon K Das; M A Malek; Dilruba Ahmed; Farhana Khanam; Firdausi Qadri; A S G Faruque; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2013-01-28       Impact factor: 2.345

7.  Identification of a common immune signature in murine and human systemic Salmonellosis.

Authors:  Seung-Joo Lee; Li Liang; Silvia Juarez; Minelva R Nanton; Esther N Gondwe; Chisomo L Msefula; Matthew A Kayala; Francesca Necchi; Jennifer N Heath; Peter Hart; Renée M Tsolis; Robert S Heyderman; Calman A MacLennan; Philip L Felgner; D Huw Davies; Stephen J McSorley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

Review 8.  Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.

Authors:  Karen H Keddy; Arvinda Sooka; Alfred Musekiwa; Anthony M Smith; Husna Ismail; Nomsa P Tau; Penny Crowther-Gibson; Frederick J Angulo; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079

Review 9.  Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.

Authors:  Samuel Kariuki; Gordon Dougan
Journal:  Ann N Y Acad Sci       Date:  2014-03-14       Impact factor: 5.691

10.  Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo.

Authors:  M-F Phoba; H De Boeck; B B Ifeka; J Dawili; O Lunguya; R Vanhoof; J-J Muyembe; C Van Geet; S Bertrand; J Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-24       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.